USPTO 2015–2025 USPTO PatentsView US Corporation

Intervet Inc.

USPTO PatentsView assignee record - 201 granted patents across 38 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

201

Total patents granted

CPC technology areas

13.7

Avg claims per patent

+18%

5-year filing velocity

The verdict

Intervet holds 201 US patents across 38 technology areas, rank #1,991 of 50,000 tracked assignees.

#1,991
of 50,000 US assignees by volume: Top 7%
by Innovation Score (55.1/100): 13.7
avg claims per patent: +18%
filing velocity, last 5 yrs

Portfolio overview

Intervet Inc. has been granted 201 US utility patents between 2015 and 2025, placing Intervet Inc. at rank #1,991 across all assignees tracked by PlainPatent. This portfolio spans 38 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.7 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Intervet Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Intervet sits between Optum, Inc. (202 patents, rank #1,987) and The Rockefeller University (201 patents, rank #1,995) - the closest US assignees by grant volume. The composite Innovation Score of 55.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 109 grants, compared with 92 in the 2015–2019 window, a +18% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Intervet Inc.'s 13.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 38 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Intervet Inc. against peers pursuing similar technology classes.

Optum

202
Tokuyama

202
Department OF Vet…

201
Enseo

201
Nippon Kayaku

201
Renesas America

201
SMK

201
The Rockefeller U…

201
Intervet ◀

201

What this shows Intervet holds 201 patents at rank #1,991, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Intervet

By rank, the assignees closest to #1,991 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Intervet's primary technology class.

Intervet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Intervet Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	16	8.0%
2016	22	10.9%
2017	20	10.0%
2018	19	9.5%
2019	15	7.5%
2020	20	10.0%
2021	16	8.0%
2022	20	10.0%
2023	14	7.0%
2024	18	9.0%
2025	21	10.4%

Which technologies does Intervet Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 150

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 129

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 77

C07K - PEPTIDES 45

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 26

C07D - HETEROCYCLIC COMPOUNDS 18

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 15

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 12

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 8

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 7

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 7

A23K - FODDER 5

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 5

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 4

Top 15 of 38 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#1,991

Across all tracked assignees

Innovation Score

55.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Intervet Inc. hold?

Intervet Inc. holds 201 US granted patents filed between 2015 and 2025, spanning 38 technology areas.

What is Intervet Inc.'s Innovation Score?

Intervet Inc. has an Innovation Score of 55.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Intervet Inc. focus on?

Intervet Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 150 patents. The company has filed patents in 38 CPC subclasses total.

Is Intervet Inc.'s patent filing rate increasing or decreasing?

Intervet Inc.'s recent filing velocity is +18% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Intervet Inc.'s patents?

Intervet Inc.'s patents average 13.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Intervet Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Intervet's 201 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Intervet ranks #1,991 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.